Chris MacDonald

Chris MacDonald

InvestorPlace Contributor

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

BRLT Stock IPO: When Does Brilliant Earth Go Public? What Is the Brilliant Earth IPO Price Range?

By Chris MacDonald, InvestorPlace Contributor

This trading week may be off to a rough start, but investors looking for some sparkle should turn to the Brilliant Earth IPO and BRLT stock.

Short Squeeze Stocks: BBIG, ATER and 3 Others Experts Think Are Ready to Pop

By Chris MacDonald, InvestorPlace Contributor

Investors looking to find the top short squeeze stocks to buy right now may want to take a look at this curated list of opportunities.

LICY Stock Charges Up as One Analyst Eyes Li-Cycle’s ‘Dominance’ in Battery Recycling

By Chris MacDonald, InvestorPlace Contributor

Here's the big analyst upgrade that has sent shares of Li-Cycle and LICY stock surging more than 10% on a down day in the markets.

DraftKings Price Predictions: Why One Analyst Sees DKNG Stock Headed to $105

By Chris MacDonald, InvestorPlace Contributor

Today, DKNG stock is down with the broader market. However, one analyst thinks this stock could have upside of 85% in the coming year.

BODY Stock: What Is Going on With Beachbody Shares Today?

By Chris MacDonald, InvestorPlace Contributor

Today, Beachbody has managed to retain most of its gains following yesterday's impressive momentum rally in BODY stock.

PTGX Stock: Why Protagonist Therapeutics Is Plunging 60% Today

By Chris MacDonald, InvestorPlace Contributor

Today, investors in Protagonist Therapeutics and PTGX stock have seen an absolutely massive decline due to an FDA hold of its clinical trial.

HLBZ Stock: What to Know as Little-Known Helbiz Rockets Higher

By Chris MacDonald, InvestorPlace Contributor

Today, investors watching Helbiz and HLBZ stock are seeing absolutely incredible triple-digit gains as volume soars for this small-cap.

Horizen Price Predictions: How High Can a Coinbase Listing Take the ZEN Crypto?

By Chris MacDonald, InvestorPlace Contributor

Today, investors are increasingly becoming interested in what the expert Horizen price predictions are as news around this crypto swirls.

AABB Stock Fans Are Waiting for Big Crypto Exchange News

By Chris MacDonald, InvestorPlace Contributor

Here's what investors may want to know about the shift Asia Broadband is making that could take AABB stock on a nice ride.

LCID Stock Revs Up on Record-Setting Nod From the EPA

By Chris MacDonald, InvestorPlace Contributor

Here's what investors interested in Lucid Motors and LCID stock should note today, as the company made an impressive EPA rating announcement.

Load More